newsfilter
← Latest News
PR Newswire·

INOVIO to Participate in Upcoming Investor Conferences

  • INOVIO (NASDAQ: INO) will present at the Jefferies Global Healthcare Conference in London on November 18 at 12:00 p.m. EST via webcast.
  • INOVIO will hold a fireside chat at the Piper Sandler 38th Annual Healthcare Conference in New York on December 1 from 2:00-2:25 p.m. EST via webcast.
  • Replays of both presentations will be available for 90 days at the provided links.
  • Members of INOVIO's management team will conduct one-on-one meetings with investors during these conferences.
  • INOVIO is a commercial-stage biotechnology company developing DNA medicines to treat & protect against HPV-related diseases, cancer, & infectious diseases.
  • Media inquiries should be directed to Josephine Galatioto at ICR Healthcare.
  • Investor inquiries should be directed to Peter Vozzo at ICR Healthcare.
Company
INOVIO Pharmaceuticals, Inc.
Keywords
INOVIO Pharmaceuticals, Inc.